Method and device for lining chambers and galleries
    1.
    发明授权
    Method and device for lining chambers and galleries 失效
    衬里室和画廊的方法和装置

    公开(公告)号:US4100749A

    公开(公告)日:1978-07-18

    申请号:US795348

    申请日:1977-05-09

    IPC分类号: E21D11/20 E21D11/22

    摘要: A method for lining chambers and galleries, especially mining and tunnelling galleries, employs resilient steel supporting frames which consist of a number of box-like section segments capable of being slid one into another and which thus, at least in the zone of overlap, constitute a closed tube. The ends of the overlapping segments are widened or compressed, as the case may be, and then inserted one into another. Each overlapping outer section segment is then mechanically compressed in the region of the overlap until ears of the so compressed segment grip behind flanges of the overlapped inner section segment. A self-locking wedge system providing means of restraint or braking is inserted between each two overlapping outer and inner section segments, and a leading tie and a deformation tie are fitted at the overlap region to the respective ends of the overlapping outer and inner section segments.

    摘要翻译: 用于衬里室和画廊的方法,特别是采矿和隧道廊,采用弹性钢支撑框架,其由许多能够滑动到另一个中的盒状截面段组成,因此至少在重叠区域构成 封闭管。 根据情况,重叠段的端部被加宽或压缩,然后将其插入另一个中。 然后每个重叠的外部段在重叠的区域中被机械地压缩,直到如此被压缩的段的耳朵夹紧在重叠的内部段的凸缘之后。 在每个两个重叠的外部和内部段之间插入提供约束或制动装置的自锁楔形系统,并且在重叠区域处将引导系带和变形连接件装配到重叠的外部和内部段段的相应端部 。

    Profile steel
    2.
    发明授权
    Profile steel 失效
    型材钢

    公开(公告)号:US4050212A

    公开(公告)日:1977-09-27

    申请号:US739641

    申请日:1976-11-08

    CPC分类号: E21D11/22 E21D11/20

    摘要: A profile steel of an about U-shaped cross section, which has a profile bottom with webs and flanges slightly inclined toward each other and extending in the direction toward the open profile side. This profile steel, which is particularly well suited as profile steel segment when preparing reinforcing frames in connection with the building of mine shafts and tunnels, has a profile bottom which at its longitudinal sides has steps directed to the open side of the profile. These steps merge with the above mentioned webs which in their turn at the ends remote from the steps end in flanges pointing toward each other.

    摘要翻译: 具有大致U形横截面的轮廓钢,其具有轮廓底部,腹板和凸缘彼此稍微倾斜并且朝向打开轮廓侧的方向延伸。 在与矿井和隧道的建造相关的加固框架制造时,特别适合作为型材钢段的型材钢具有轮廓底部,其纵向侧面具有指向轮廓的敞开侧的台阶。 这些步骤与上述的腹板相结合,这些腹板在距离彼此指向的凸缘中远离台阶端的端部。

    Pharmaceutical tablets with diffractive microstructure and compression tools for producing such tablets
    3.
    发明授权
    Pharmaceutical tablets with diffractive microstructure and compression tools for producing such tablets 有权
    具有衍生微结构的药物片剂和用于生产这种片剂的压缩工具

    公开(公告)号:US09592646B2

    公开(公告)日:2017-03-14

    申请号:US12308484

    申请日:2007-06-12

    摘要: A tablet for pharmaceutical use has on at least one part of its surface a diffractive microstructure which generates diffraction effects which can be perceived in the visible spectral range and which serve as visual safety feature. The tablet includes a plurality of individual powder particles, where the diffractive microstructures are impressed into the surface of the individual powder particles. A compression tool to produce such tablets has on one pressing surface of the compression tool micro-structures, where the microstructures have dimensions which are smaller than the dimensions of the individual crystallites of the material of the pressing surface of the compression tool. The micro-structures of the compression tool can be produced for example by ion etching or by imprinting.

    摘要翻译: 用于药物用途的片剂在其表面的至少一部分上具有衍生微结构,其产生可在可见光谱范围内感觉并且用作视觉安全特征的衍射效应。 片剂包括多个单独的粉末颗粒,其中衍射微结构被印刷到各个粉末颗粒的表面中。 用于生产这种片剂的压缩工具具有在压缩工具微结构的一个按压表面上,其中微结构具有的尺寸小于压缩工具的压制表面的材料的各个微晶的尺寸。 压缩工具的微结构可以例如通过离子蚀刻或压印来制造。

    PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLPROPANONES
    4.
    发明申请
    PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLPROPANONES 有权
    制备取代的苯丙酮的方法

    公开(公告)号:US20150031919A1

    公开(公告)日:2015-01-29

    申请号:US14379013

    申请日:2012-02-28

    IPC分类号: C07C45/45

    摘要: The invention relates to a process for the preparation of a compound of formula (I) wherein the substituents are defined as in claim 1, which process comprises adding a compound of formula (II), wherein R1, R2 and R3 have the meanings as described under formula (I), in the presence of an inert organic solvent, to a mixture comprising an organic nitrite of formula (III) R4—O—N═O, wherein R4 is C1-C8alkyl, a compound of formula (IV), and an inert organic solvent.

    摘要翻译: 本发明涉及一种制备式(I)化合物的方法,其中取代基如权利要求1所定义,该方法包括加入式(II)化合物,其中R 1,R 2和R 3具有如上所述的含义 在式(I)的存在下,在惰性有机溶剂的存在下,向包含式(III)的有机亚硝酸酯的R 4 -O-N = O(其中R 4为C 1 -C 8烷基),式(IV)的化合物, 和惰性有机溶剂。

    Manufacturing Solid Pharmaceutical Dosage Forms With Visible Micro- And Nanostructured Surfaces And Micro- And Nanostructured Pharmaceutical Dosage Form
    5.
    发明申请
    Manufacturing Solid Pharmaceutical Dosage Forms With Visible Micro- And Nanostructured Surfaces And Micro- And Nanostructured Pharmaceutical Dosage Form 审中-公开
    制造具有可见微米和纳米结构表面的固体药物剂型和微米和纳米结构的药物剂型

    公开(公告)号:US20140255482A9

    公开(公告)日:2014-09-11

    申请号:US12761993

    申请日:2010-04-16

    IPC分类号: A61K9/20

    CPC分类号: A61K9/2072 A61J3/007

    摘要: A solid pharmaceutical dosage form [19] has micro- or nanostructures [10a, 10b, 10c, 10d] impressed on the surface thereof or an interface thereof. The dosage form [19] includes a suitable quantity and distribution of ingredients, such as one or more dyes, so as to enhance the optical contrast effect, C, caused by the micro- or nanostructures so that the micro- or nanostructures are observable by the human eye and thereby able to provide anti-counterfeiting characteristics to the dosage form.

    摘要翻译: 固体药物剂型[19]具有在其表面或其界面上施加的微观或纳米结构[10a,10b,10c,10d]。 剂型[19]包括适当的成分数量和分布,例如一种或多种染料,以增强由微结构或纳米结构引起的光学对比效应C,使得微观或纳米结构可被 人眼,从而能够向剂型提供防伪特征。

    PYRAZOL-4-YL CARBOXAMIDE DERIVATIVES AS MICROBIOCIDES
    9.
    发明申请
    PYRAZOL-4-YL CARBOXAMIDE DERIVATIVES AS MICROBIOCIDES 有权
    PYRAZOL-4-YL羧酰胺衍生物作为微生物

    公开(公告)号:US20130281505A1

    公开(公告)日:2013-10-24

    申请号:US13978482

    申请日:2012-01-02

    摘要: Compounds of formula (I) wherein R1 is C1-C4alkyl, C1-C4haloalkyl or C1-C4alkoxy; R2 is C1-C4alkyl; R3 is hydrogen or halogen; R4 is hydrogen, C1-C4alkyl or C1-C4halogenalkyl; R5 is hydrogen, halogen or C1-C4alkyl; R6 is hydrogen, halogen, C1-C4alkyl, C2-C6alkenyl or C3-C6alkynyl; R7 is hydrogen, halogen, C1-C6alkyl, C2-C6alkenyl, C3-C6alkynyl, C3-C6cycloalkyl-C3-C6alkynyl, C1-C6haloalkyl, C1-C6haloalkoxy, C2-C6haloalkenyl, or C2-C6haloalkenyloxy; R5 is hydrogen, halogen, C1-C4alkyl, C2-C6alkenyl, C3-C6alkynyl, amino, C1-C6alkylcarbonylamino, C1-C6alkoxycarbonylamino or C3-C6cycloalkylcarbonylamino; R9 is hydrogen, halogen, C1-C6alkyl, C1-C6alkoxy, C2-C6alkenyl, C3-C6alkynyl, C3-C6cycloalkyl-C3-C6alkynyl, halophenoxy, halophenyl, C1-C6haloalkyl, C1-C6haloalkoxy, C2-C6haloalkenyl, or C2-C6haloalkenyloxy; R10 is hydrogen, halogen, C1-C4alkyl, C1-C6alkoxy, C2-C6alkenyl or C3-C6alkynyl; X is CH2, O or S; n is 0, 1 or 2; and agronomically acceptable salts/isomers/structural isomers/stereoisomers/diastereoisomers/enantiomers/tautomers and N-oxides of those compounds, are suitable for use as microbiocides.

    摘要翻译: 其中R1是C1-C4烷基,C1-C4卤代烷基或C1-C4烷氧基的式(Ⅰ)化合物; R2是C1-C4烷基; R3是氢或卤素; R4是氢,C1-C4烷基或C1-C4卤代烷基; R5是氢,卤素或C1-C4烷基; R6是氢,卤素,C1-C4烷基,C2-C6链烯基或C3-C6炔基; R 7是氢,卤素,C 1 -C 6烷基,C 2 -C 6烯基,C 3 -C 6炔基,C 3 -C 6环烷基-C 3 -C 6炔基,C 1 -C 6卤代烷基,C 1 -C 6卤代烷氧基,C 2 -C 6卤代烯基或C 2 -C 6卤代烯氧基; R 5是氢,卤素,C 1 -C 4烷基,C 2 -C 6烯基,C 3 -C 6炔基,氨基,C 1 -C 6烷基羰基氨基,C 1 -C 6烷氧基羰基氨基或C 3 -C 6环烷基羰基氨基; R 9是氢,卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,C 2 -C 6烯基,C 3 -C 6炔基,C 3 -C 6环烷基-C 3-C 6炔基,卤代苯氧基,卤代苯基,C 1 -C 6卤代烷基,C 1 -C 6卤代烷氧基,C 2 -C 6卤代烯基或C 2 -C 6卤代烯氧基 ; R 10是氢,卤素,C 1 -C 4烷基,C 1 -C 6烷氧基,C 2 -C 6烯基或C 3 -C 6炔基; X是CH 2,O或S; n为0,1或2; 并且这些化合物的农学上可接受的盐/异构体/结构异构体/立体异构体/非对映异构体/对映体/互变异构体和N-氧化物适合用作杀微生物剂。

    PYRAZOLECARBOXAMIDE DERIVATIVES AND THEIR USE AS MICROBIOCIDES
    10.
    发明申请
    PYRAZOLECARBOXAMIDE DERIVATIVES AND THEIR USE AS MICROBIOCIDES 有权
    吡咯并吡啶衍生物及其作为微生物使用

    公开(公告)号:US20130072535A1

    公开(公告)日:2013-03-21

    申请号:US13700706

    申请日:2011-05-12

    摘要: Compounds of Formula (I) wherein R1 is C1-C4alkyl or C1-C4 haloalkyl; R2 is C1-C4alkyl; R3 is hydrogen or halogen; R4 is hydrogen, C1-C4alkyl or C1-C4halogenalkyl; R5 is hydrogen, halogen, C1-C4alkyl or C1-C4halogenalkyl; R6 is hydrogen, halogen, C1-C4alkyl, C2-C6alkenyl or C3-C6alkinyl; R7 is hydrogen, halogen, C1-C6alkyl, C2-C6alkenyl, C3-C6alkinyl, C3-C6cycloalkyl-C3-C6alkinyl, halophenoxy, halophenyi, C1-C6haloalkyl, C1-C6haloakoxy, C2-C6haloalkenyl, or C2-C6haloalkenyloxy; R8 is hydrogen, halogen, C1-C4alkyl, C2-C6alkenyl or C3-C6alkinyl; with the provisio that at least one of R6, R7 and R8 is different from hydrogen; n is 0 or 1, are suitable for use as microbriocides.

    摘要翻译: 式(I)的化合物,其中R 1是C 1 -C 4烷基或C 1 -C 4卤代烷基; R2是C1-C4烷基; R3是氢或卤素; R4是氢,C1-C4烷基或C1-C4卤代烷基; R5是氢,卤素,C1-C4烷基或C1-C4卤代烷基; R 6是氢,卤素,C 1 -C 4烷基,C 2 -C 6烯基或C 3 -C 6炔基; R 7是氢,卤素,C 1 -C 6烷基,C 2 -C 6烯基,C 3 -C 6炔基,C 3 -C 6环烷基-C 3 -C 6炔基,卤代苯氧基,卤代苯基,C 1 -C 6卤代烷基,C 1 -C 6卤代烷氧基,C 2 -C 6卤代烯基或C 2 -C 6卤代烯氧基; R8是氢,卤素,C1-C4烷基,C2-C6链烯基或C3-C6炔基; 条件是R6,R7和R8中的至少一个不同于氢; n为0或1,适用于微生物。